JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 46 filers reported holding JANUX THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $534,734 | -15.1% | 53,049 | 0.0% | 0.00% | – |
| Q2 2023 | $629,692 | -2.0% | 53,049 | -0.1% | 0.00% | – |
| Q1 2023 | $642,401 | -8.8% | 53,091 | -0.8% | 0.00% | – |
| Q4 2022 | $704,661 | +3.8% | 53,505 | +6.8% | 0.00% | – |
| Q3 2022 | $679,000 | +31.3% | 50,093 | +18.2% | 0.00% | – |
| Q2 2022 | $517,000 | -21.7% | 42,386 | -7.9% | 0.00% | – |
| Q1 2022 | $660,000 | -8.5% | 46,001 | +25.9% | 0.00% | – |
| Q4 2021 | $721,000 | +5.9% | 36,537 | +16.1% | 0.00% | – |
| Q3 2021 | $681,000 | – | 31,473 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,670,644 | $105,869,000 | 2.82% |
| 5AM Venture Management, LLC | 446,266 | $5,449,000 | 1.35% |
| Samsara BioCapital, LLC | 360,414 | $4,401,000 | 1.17% |
| BVF INC/IL | 1,470,334 | $17,953,000 | 0.87% |
| Orbimed Advisors | 2,836,386 | $34,632,000 | 0.63% |
| EcoR1 Capital, LLC | 1,421,319 | $17,354,000 | 0.60% |
| Parkwood LLC | 33,750 | $412,000 | 0.07% |
| Woodline Partners LP | 286,383 | $3,497,000 | 0.05% |
| Cerity Partners LLC | 150,933 | $1,843,000 | 0.02% |
| JANUS HENDERSON GROUP PLC | 2,127,797 | $25,966,000 | 0.02% |